Dianthus Therapeutics
DNTH
DNTH
95 hedge funds and large institutions have $248M invested in Dianthus Therapeutics in 2020 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 31 increasing their positions, 23 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
95
Holders Change
+23
Holders Change %
+31.94%
% of All Funds
1.95%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
26
Increased
31
Reduced
23
Closed
3
Calls
$4K
Puts
$117K
Net Calls
-$113K
Net Calls Change
-$113K
Top Buyers
| 1 |
1
UBS AM
Chicago,
Illinois
|
$4.51M |
| 2 |
EAM
2
Eventide Asset Management
Boston,
Massachusetts
|
$17.7M |
| 3 |
EC
3
EcoR1 Capital
San Francisco,
California
|
$3.38M |
| 4 |
AG
4
Artal Group
Luxembourg
|
$3.38M |
| 5 |
CH
5
CVI Holdings
Wilmington,
Delaware
|
$3.11M |
